Cell Counting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Description
Cell Counting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global cell counting market size reached US$ 10.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.5 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2022-2028.
Cell counting refers to a technique used for the analysis of the cells or micelles that are usually suspended in blood or other body fluids. Some of the common instruments used for cell counting includes hemocytometers, spectrophotometers, flow cytometers, automated cell counters, etc. Cell counting aids in classifying cell types and detecting disease through probes to develop the best treatment plan for the patient. It also helps in understanding the structure and composition of the cells for chromosome analysis, protein expression, cancer diagnosis, hematological malignancies, etc. As a result, cell counting is extensively used across hospitals, diagnostic laboratories, research and academic institutes, pharmaceutical and biotechnology companies, etc.
The rising prevalence of various chronic ailments, such as cancer, HIV-AIDS, leukemia, Alzheimer’s, etc., is propelling the demand for cell counting techniques. Moreover, the growing adoption of cell counting instruments across diverse medical fields, such as molecular biology, immunology, pathology, etc., for developing next-generation therapeutics is also augmenting the market growth. In addition to this, the increasing utilization of cell counting for the identification and determination of primary tumor, circulating tumor, and metastatic tumor is further bolstering the market growth. Additionally, the widespread adoption of stem cell therapy is also propelling the demand for various cell counting instruments on a global level. In line with this, the rising awareness towards numerous benefits of cell counting technique in immunophenotyping, cell sorting, cell proliferation assays and intracellular calcium flux is further driving the market growth. Moreover, the increasing investments by several government bodies in extensive R&D activities pertaining to the fields of biotechnology, oncology stem cell therapeutics, etc., are also bolstering the adoption of cell counting techniques. In the coming years, the introduction of automated product variants with enhanced ability to process larger sample sizes at a higher speed will continue to drive the global market for cell counting.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cell counting market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type and end user.
Breakup by Product Type:
Consumables
Reagents
Assay Kits
Microplates
Accessories
Instruments
Spectrophotometers
Flow Cytometers
Hematology Analyzers
Cell Counters
Breakup by End User:
Hospitals and Diagnostic Laboratories
Research and Academic Institutes
Pharmaceutical and Biotechnology Companies
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd. (Roche Holding AG)., Merck & Co. Inc., PerkinElmer Inc. and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global cell counting market performed so far and how will it perform in the coming years?
What are the key regional markets?
What is the impact of COVID-19 on the global cell counting market?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the market?
What is the structure of the global cell counting market and who are the key players?
What is the degree of competition in the market?
Table of Contents
149 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Global Cell Counting Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
- 6 Market Breakup by Product Type
- 6.1 Consumables
- 6.1.1 Market Trends
- 6.1.2 Major Types
- 6.1.2.1 Reagents
- 6.1.2.2 Assay Kits
- 6.1.2.3 Microplates
- 6.1.2.4 Accessories
- 6.1.3 Market Forecast
- 6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Major Types
- 6.2.2.1 Spectrophotometers
- 6.2.2.2 Flow Cytometers
- 6.2.2.3 Hematology Analyzers
- 6.2.2.4 Cell Counters
- 6.2.3 Market Forecast
- 7 Market Breakup by End User
- 7.1 Hospitals and Diagnostic Laboratories
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Research and Academic Institutes
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Pharmaceutical and Biotechnology Companies
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.2 Asia Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
- 9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
- 10 Value Chain Analysis
- 11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
- 12 Competitive Landscape
- 12.1 Market Structure
- 12.2 Key Players
- 12.3 Profiles of Key Players
- 12.3.1 Agilent Technologies Inc.
- 12.3.1.1 Company Overview
- 12.3.1.2 Product Portfolio
- 12.3.1.3 Financials
- 12.3.1.4 SWOT Analysis
- 12.3.2 Becton, Dickinson and Company.
- 12.3.2.1 Company Overview
- 12.3.2.2 Product Portfolio
- 12.3.2.3 Financials
- 12.3.2.4 SWOT Analysis
- 12.3.3 Bio-Rad Laboratories Inc.
- 12.3.3.1 Company Overview
- 12.3.3.2 Product Portfolio
- 12.3.3.3 Financials
- 12.3.3.4 SWOT Analysis
- 12.3.4 Danaher Corporation
- 12.3.4.1 Company Overview
- 12.3.4.2 Product Portfolio
- 12.3.4.3 Financials
- 12.3.4.4 SWOT Analysis
- 12.3.5 F. Hoffmann-La Roche Ltd. (Roche Holding AG)
- 12.3.5.1 Company Overview
- 12.3.5.2 Product Portfolio
- 12.3.5.3 Financial
- 12.3.5.4 SWOT Analysis
- 12.3.6 Merck & Co. Inc.
- 12.3.6.1 Company Overview
- 12.3.6.2 Product Portfolio
- 12.3.6.3 Financials
- 12.3.6.4 SWOT Analysis
- 12.3.7 PerkinElmer Inc.
- 12.3.7.1 Company Overview
- 12.3.7.2 Product Portfolio
- 12.3.7.3 Financials
- 12.3.7.4 SWOT Analysis
- 12.3.8 Thermo Fisher Scientific Inc.
- 12.3.8.1 Company Overview
- 12.3.8.2 Product Portfolio
- 12.3.8.3 Financials
- 12.3.8.4 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
